50 results on '"Geisbert, Thomas W."'
Search Results
2. Revisiting the minimum incubation period of Zaire ebolavirus
3. Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection
4. Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection
5. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever
6. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
7. Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses
8. Pan-ebolavirus protective therapy by two multifunctional human antibodies
9. A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery
10. Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
11. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever
12. Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
13. Asymmetric and Non-Stoichiometric Recognition Results in Broad Protection Against Ebolaviruses by a Two-Antibody Cocktail
14. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein
15. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
16. Ebola and Marburg Virus Infection in Bats Induces a Systemic Response
17. Use of reverse genetics to inform Ebola outbreak responses
18. A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge
19. The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus
20. Antibody therapy for Lassa fever
21. Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization
22. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates
23. Predicting outcome and improving treatment for Lassa fever
24. Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop
25. Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo
26. First Ebola virus vaccine to protect human beings?
27. Persistence of Ebola virus RNA in seminal fluid
28. Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies
29. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins
30. The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway
31. A treatment for and vaccine against the deadly Hendra and Nipah viruses
32. Mutual Antagonism between the Ebola Virus VP35 Protein and the RIG-I Activator PACT Determines Infection Outcome
33. Animal models for highly pathogenic emerging viruses
34. Label-free multiplexed virus detection using spectral reflectance imaging
35. Ebola haemorrhagic fever
36. Inhibition of heat-shock protein 90 reduces Ebola virus replication
37. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
38. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
39. Viral Hemorrhagic Fevers
40. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment
41. Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever
42. Detection and identification of Variola virus in fixed human tissue after prolonged archival storage
43. Pathogenesis of Ebola Hemorrhagic Fever in Primate Models
44. Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
45. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys
46. Detection and identification of Variola virus in fixed human tissue after prolonged archival storage
47. Evidence against an Important Role for Infectivity-Enhancing Antibodies in Ebola Virus Infections
48. The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis)
49. Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
50. Toxicity and kinetics of [3H]microcystin-LR in isolated perfused rat livers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.